Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2011 (2011), Article ID 747648, 3 pages
http://dx.doi.org/10.1155/2011/747648
Case Report

The Use of Intravitreal Ranibizumab for Choroidal Neovascularization Associated with Vogt-Koyanagi-Harada Syndrome

The Institute of Ophthalmology and Visual Science, University of Medicine and Dentistry of New Jersey, Newark, NJ 07103, USA

Received 6 December 2010; Accepted 10 June 2011

Academic Editor: Marco A. Zarbin

Copyright © 2011 A. M. Kolomeyer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Maezawa, A. Yano, M. Taniguchi, and S. Kojima, “The role of cytotoxic T lymphocytes in the pathogenesis of Vogt-Koyanagi-Harada disease,” Ophthalmologica, vol. 185, no. 3, pp. 179–186, 1982. View at Google Scholar · View at Scopus
  2. H. D. Perry and R. L. Font, “Clinical and histopathologic observations in severe Vogt Koyanagi Harada syndrome,” American Journal of Ophthalmology, vol. 83, no. 2, pp. 242–254, 1977. View at Google Scholar · View at Scopus
  3. S. Lertsumitkul, S. M. Whitcup, R. B. Nussenblatt, and C. C. Chan, “Subretinal fibrosis and choroidal neovascularization in Vogt-Koyanagi-Harada syndrome,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 237, no. 12, pp. 1039–1045, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. R. S. Moorthy, L. P. Chong, R. E. Smith, and N. A. Rao, “Subretinal neovascular membranes in Vogt-Koyanagi-Harada syndrome,” American Journal of Ophthalmology, vol. 116, no. 2, pp. 164–170, 1993. View at Google Scholar · View at Scopus
  5. H. E. Grossniklaus, J. X. Ling, T. M. Wallace et al., “Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization,” Molecular Vision, vol. 8, pp. 119–126, 2002. View at Google Scholar · View at Scopus
  6. W. M. Chan, T. Y. Y. Lai, D. T. L. Liu, and D. S. C. Lam, “Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin,” American Journal of Ophthalmology, vol. 143, no. 6, pp. 977–983, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. L. Arias, N. Planas, S. Prades et al., “Intravitreal bevacizumab (Avastin) for choroidal neovascularisation secondary to pathological myopia: 6-month results,” British Journal of Ophthalmology, vol. 92, no. 8, pp. 1035–1039, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. T. H. C. Tran, C. Fardeau, C. Terrada, G. Ducos De Lahitte, B. Bodaghi, and P. Lehoang, “Intravitreal bevacizumab for refractory choroidal neovascularization (CNV) secondary to uveitis,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 246, no. 12, pp. 1685–1692, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. M. Vadalà, A. Pece, S. Cipolla et al., “Is ranibizumab effective in stopping the loss of vision for choroidal neovascularisation in pathologic myopia? A long-term follow-up study,” British Journal of Ophthalmology, vol. 95, no. 5, pp. 657–661, 2011. View at Publisher · View at Google Scholar · View at PubMed
  10. L. Wu, T. Evans, M. Saravia, A. Schlaen, and C. Couto, “Intravitreal bevacizumab for choroidal neovascularization secondary to Vogt-Koyanagi-Harada syndrome,” Japanese Journal of Ophthalmology, vol. 53, no. 1, pp. 57–60, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. S. R. Nowilaty, M. Bouhaimed, and Photodynamic Therapy Study Group, “Photodynamic therapy for subfoveal choroidal neovascularisation in Vogt-Koyanagi-Harada disease,” British Journal of Ophthalmology, vol. 90, no. 8, pp. 982–986, 2006. View at Publisher · View at Google Scholar · View at PubMed
  12. M. Soheilian, M. Movaseghi, A. Ramezani, and G. A. Peyman, “Pilot study of safety and effect of combined intravitreal bevacizumab and methotrexate for neovascular age-related macular degeneration,” European Journal of Ophthalmology, vol. 21, no. 1, pp. 77–82, 2011. View at Publisher · View at Google Scholar · View at Scopus